Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Ceftriaxone recalled?

Yes — there is an active recall. 3 ongoing FDA recalls mention Ceftriaxone (38 total). Check the affected lots below.

Most common reason: Sterility / contamination (26 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Ceftriaxone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Ceftriaxone recalls on record

none so far in 2026; 38 on record, newest first
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-644-01 D-0358-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-633-01 D-0357-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-622-01 D-0356-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-611-01 D-0355-2019
Class III · Low risk

CEFTRIAXONE for Injection USP

CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

Terminated Failed specification Aidarex Pharmaceuticals LLC NDC 53217-0117-01 D-0974-2016
Class III · Low risk

Ceftriaxone Sodium

CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications.

Terminated Failed specification Lupin Pharmaceuticals Inc. D-0955-2016
Class III · Low risk

Ceftriaxone for Injection USP

CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Terminated Failed specification Lupin Pharmaceuticals Inc. NDC 68180-644-01 D-0954-2016